144 related articles for article (PubMed ID: 11279303)
21. Molecular basis for the effect of lipid lowering drugs on growth factors after de-endothelialization.
Zhou Y; Liu X; She M
Chin Med J (Engl); 2001 Sep; 114(9):976-82. PubMed ID: 11780395
[TBL] [Abstract][Full Text] [Related]
22. Systemic transforming growth factor-beta in patients with bone marrow fibrosis--pathophysiological implications.
Rameshwar P; Chang VT; Thacker UF; Gascón P
Am J Hematol; 1998 Oct; 59(2):133-42. PubMed ID: 9766798
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical analysis of cortical and cancellous bone after radiation and the effect of platelet-rich plasma on autogenous bone grafting.
Aghaloo TL; Le AD; Freymiller EG; Avera S; Shimizu K; Nishimura RD
Int J Oral Maxillofac Implants; 2006; 21(4):535-42. PubMed ID: 16955603
[TBL] [Abstract][Full Text] [Related]
24. Regulation of insulin-like growth factor-II synthesis in bone cell cultures by skeletal growth factors.
Gabbitas B; Pash J; Canalis E
Endocrinology; 1994 Jul; 135(1):284-9. PubMed ID: 8013362
[TBL] [Abstract][Full Text] [Related]
25. Transforming growth factor beta 1 downregulates the platelet-derived growth factor alpha-receptor subtype on human lung fibroblasts in vitro.
Bonner JC; Badgett A; Lindroos PM; Osornio-Vargas AR
Am J Respir Cell Mol Biol; 1995 Oct; 13(4):496-505. PubMed ID: 7546780
[TBL] [Abstract][Full Text] [Related]
26. Interferon alpha2b directly induces fibroblast proliferation and transforming growth factor beta secretion of macrophages.
Wickenhauser C; Schmitz B; Selbach B; Brockbals C; Manske O; Thiele J
Br J Haematol; 2000 May; 109(2):296-304. PubMed ID: 10848815
[TBL] [Abstract][Full Text] [Related]
27. Platelet derived growth factor receptor-beta (PDGFRβ) expression is limited to activated stromal cells in the bone marrow and shows a strong correlation with the grade of myelofibrosis.
Bedekovics J; Kiss A; Beke L; Károlyi K; Méhes G
Virchows Arch; 2013 Jul; 463(1):57-65. PubMed ID: 23748876
[TBL] [Abstract][Full Text] [Related]
28. [Electron-immunostaining characteristics of platelet-derived growth factor, transforming growth factor beta1 and their receptors in epiretinal membranes].
Wang F; Xu X; Zhang X; Yan Y
Zhonghua Yan Ke Za Zhi; 2000 Sep; 36(5):369-71, 24. PubMed ID: 11853632
[TBL] [Abstract][Full Text] [Related]
29. Elevated levels of basic fibroblast growth factor in megakaryocytes and platelets from patients with idiopathic myelofibrosis.
Martyré MC; Le Bousse-Kerdiles MC; Romquin N; Chevillard S; Praloran V; Demory JL; Dupriez B
Br J Haematol; 1997 May; 97(2):441-8. PubMed ID: 9163611
[TBL] [Abstract][Full Text] [Related]
30. The effect of locally administered anti-growth factor antibodies on neointimal hyperplasia formation in expanded polytetrafluoroethylene grafts.
Sapienza P; di Marzo L; Cucina A; Borrelli V; Mosiello G; Basile U; Iacovitti S; Cavallaro A
Ann Vasc Surg; 2009; 23(3):398-409. PubMed ID: 19427566
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms by which high-dose estrogen therapy produces anabolic skeletal effects in postmenopausal women: role of locally produced growth factors.
Bord S; Beavan S; Ireland D; Horner A; Compston JE
Bone; 2001 Sep; 29(3):216-22. PubMed ID: 11557364
[TBL] [Abstract][Full Text] [Related]
32. Peripheral T cell lymphoma, not otherwise specified with myelofibrosis: report of a case with review of the literature.
Sekiguchi Y; Shirane S; Shimada A; Ichikawa K; Wakabayashi M; Sugimoto K; Tomita S; Izumi H; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
Int J Clin Exp Pathol; 2015; 8(4):4186-203. PubMed ID: 26097612
[TBL] [Abstract][Full Text] [Related]
33. Growth factor responsiveness of human articular chondrocytes: distinct profiles in primary chondrocytes, subcultured chondrocytes, and fibroblasts.
Guerne PA; Sublet A; Lotz M
J Cell Physiol; 1994 Mar; 158(3):476-84. PubMed ID: 8126071
[TBL] [Abstract][Full Text] [Related]
34. Regulation of PDGF and its receptors in fibrotic diseases.
Bonner JC
Cytokine Growth Factor Rev; 2004 Aug; 15(4):255-73. PubMed ID: 15207816
[TBL] [Abstract][Full Text] [Related]
35. Growth factor and growth factor receptor localization in the hair follicle bulge and associated tissue in human fetus.
Akiyama M; Smith LT; Holbrook KA
J Invest Dermatol; 1996 Mar; 106(3):391-6. PubMed ID: 8648166
[TBL] [Abstract][Full Text] [Related]
36. Specific inhibition of human skin fibroblast chemotaxis to platelet-derived growth factor A-chain homodimer by transforming growth factor-beta1.
Soma Y; Mizoguchi M; Yamane K; Yazawa N; Kubo M; Ihn H; Kikuchi K; Tamaki K
Arch Dermatol Res; 2002 Feb; 293(12):609-13. PubMed ID: 11875643
[TBL] [Abstract][Full Text] [Related]
37. Interactions of cultured endothelial cells with TGF-beta, bFGF, PDGF and IGF-I.
Boes M; Dake BL; Bar RS
Life Sci; 1991; 48(8):811-21. PubMed ID: 1994187
[TBL] [Abstract][Full Text] [Related]
38. Up-regulation of bone morphogenetic protein receptor IB by growth factors enhances BMP-2-induced human bone cell functions.
Singhatanadgit W; Salih V; Olsen I
J Cell Physiol; 2006 Dec; 209(3):912-22. PubMed ID: 17001689
[TBL] [Abstract][Full Text] [Related]
39. Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-beta.
Evanko SP; Raines EW; Ross R; Gold LI; Wight TN
Am J Pathol; 1998 Feb; 152(2):533-46. PubMed ID: 9466580
[TBL] [Abstract][Full Text] [Related]
40. Transforming growth factor β- and interleukin 13-producing mast cells are associated with fibrosis in bone marrow.
Nakayama S; Yokote T; Hiraoka N; Akioka T; Nishiwaki U; Miyoshi T; Iwaki K; Fumimoto A; Masuda Y; Hatooka J; Fujimoto M; Nishimura Y; Tsuji M
Hum Pathol; 2017 Apr; 62():180-186. PubMed ID: 28159675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
